Recently submitted manuscripts:

1. Feridooni T, Mac Donald D, Shao D, Yeung P, Agu RU. Cardio-protective potential of antiischemic drugs against chemotherapy-induced cardiotoxicity in H9C2 cell line.

2. Shao D, Massoud D, Clarke D, Cowley D, Renton K, Agu RU. Transport of coumarin-conjugated fluorescent dipeptides by hPEPT transporters in human nasal epithelium.



Google Scholars:

Google Scholar Page



Our latest papers (2013-2012)

1. Shao D, Massoud E, Anand U, Parikh A, Cowley E, Clarke D, Agu R U. Organic cation transporters in human nasal epithelium: Activity and localization studies. Therapeuty Delivery. In press (2013)

2. Shao D, Massoud E, Clarke D, Cowley E, Renton K, Agu RU. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro. Int J Pharm. 2013 Jan 30;441(1-2):334-42.

3. Macdonald C, Shao D, Oli A, Agu RU. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies. J Drug Target. 2013 Jan; 21(1):97-106.

4. Anand U, Feridooni T, Agu RU. Novel Mucoadhesive Polymers for Nasal Drug Delivery. In Recent Advances in Novel Drug Carrier Systems. 2012. Intech. Rijeka, Croatia.



Books:

1. Agu RU, Adikwu MU, Udeani G, Anyakorah C, Nelson T, Idemyor V (editors). Integrating Current African Concepts and Practice of Pharmaceutical Sciences and Pharmacy in a New World. Pyramid Publications, Aurora Illinois, USA. 2013 (in press).

2. Agu, R.U. Biopharmaceutical relevance of human nasal primary cell culture systems. Acta Biomedica Lovaniensa (Leuven University Press Belgium), 1-145, 2002 (ISBN 90 5867 265 4).



Book Chapters:

1. Anand U, Feridooni T, Agu RU. Novel Mucoadhesive Polymers for Nasal Drug Delivery. In Recent Advances in Novel Drug Carrier Systems. 2012. Intech. Rijeka, Croatia.

2. Agu, RU, Lyzenga WJ, Ugwoke MI. Novel Nasal Delivery Systems Based on Synthetic Biopolymers. In Biopolymers in Drug Delivery: Recent Advances and Challenges. Adikwu MU and Esimone E. (Eds). Bentham Press, UK (Chapter 9), 2009.

3. Agu RU, Ugwoke MI. Nasal Models for Preclinical Drug Development Studies. In Drug absorption studies (Eds. Ehrhardt C & Kwang-Jin K. American Association of Pharmaceutical Scientists Press 2008, p 112-134, ISN 978-0-387-74900-6.

4. Builders F, Agu RU. Formulation and Quality Control in Phytomedicines Development. In Integrating Current African Concepts and Practice of Pharmaceutical Sciences and Pharmacy in a New World. Eds (Agu RU, Adikwu MU, Udeani G, Anyakorah C, Nelson T, Idemyor V. ). Pyramid Publications, Aurora Illinois, USA. 2011 (in press).

5. Nzekwe I, Agu RU. Malaria, Nanotechnology and Overcoming Chloroquine Resistance. In Integrating Current African Concepts and Practice of Pharmaceutical Sciences and Pharmacy in a New World. Eds (Agu RU, Adikwu MU, Udeani G, Anyakorah C, Nelson T, Idemyor V. ). Pyramid Publications, Aurora Illinois, USA. 2011 (in press).

Contact

Name: Remi U. Agu, B. Pharm., M. Pharm., PhD, Associate Professor
Address: College of Pharmacy
Dalhousie University
5968 College Street,
PO Box 15000 Halifax, Nova Scotia
Canada B3H 4R2

 

    Phone: +1 902 494 2092
    Email: remigius.agu@dal.ca